Published in Arch Environ Health on December 01, 1967
Use of reminders to increase compliance with tetanus booster vaccination. CMAJ (1992) 2.01
Cost-effectiveness of primary tetanus vaccination among elderly Canadians. CMAJ (1988) 1.57
Immunity to diphtheria and tetanus in inner-city women of childbearing age. Am J Public Health (1989) 0.88
On the role of sexual behavior in the spread of hepatitis B infection. Ann Intern Med (1975) 4.11
Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med (1992) 3.42
Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate. Antimicrob Agents Chemother (1994) 3.26
The multiple risk factor intervention trial (MRFIT) II. The development of the protocol. Prev Med (1981) 3.02
Prevalence of alcoholism in general municipal hospital population. N Y State J Med (1971) 2.79
Long-incubation post-transfusion hepatitis without serological evidence of exposure to hepatitis-B virus. Lancet (1974) 2.77
Past and current roles for cephalosporin antibiotics in treatment of meningitis. Emphasis on use in gram-negative bacillary meningitis. Am J Med (1981) 2.68
Infective endocarditis at the Presbyterian Hospital in New York City from 1938-1967. Am J Med (1971) 2.66
Listeria and gram-negative bacillary meningitis in New York City, 1972-1979. Frequent causes of meningitis in adults. Am J Med (1981) 2.36
Septicemia with non-typhoid salmonella. Medicine (Baltimore) (1974) 2.31
Comparative fetal mortality in maternal virus diseases. A prospective study on rubella, measles, mumps, chicken pox and hepatitis. N Engl J Med (1966) 2.28
Bactericidal effects of antibiotics on slowly growing and nongrowing bacteria. Antimicrob Agents Chemother (1991) 2.26
Immunologic distinction between infectious and serum hepatitis. N Engl J Med (1970) 2.16
Bone and joint infections due to Salmonella. J Infect Dis (1978) 2.14
Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa. Antimicrob Agents Chemother (1980) 2.12
Antimicrobial resistance and R-factor transfer among isolates of Salmonella in the northeastern United States: a comparison of human and animal isolates. J Infect Dis (1975) 2.09
Hospital epidemiology. Its development and potential. JAMA (1965) 2.05
A serologic study of cytomegalovirus infections associated with blood transfusions. N Engl J Med (1971) 2.02
Traditional risk factors and ischemic stroke in young adults: the Baltimore-Washington Cooperative Young Stroke Study. Arch Neurol (1996) 1.94
Cerebral infarction in young adults: the Baltimore-Washington Cooperative Young Stroke Study. Neurology (1998) 1.75
Viral syndromes and renal homograft rejection. Ann Surg (1972) 1.74
The association of viral and mycoplasma infections with recurrence of wheezing in the asthmatic child. Ann Allergy (1970) 1.70
The medical sequelae of narcotic addiction. Ann Intern Med (1967) 1.68
Acquisition of antibody to hepatitis B antigen in three socioeconomically different medical populations. Lancet (1972) 1.67
Infectious disease problems of narcotic addicts. Arch Intern Med (1971) 1.62
Low level rubella immunity detected by ELISA and specific lymphocyte transformation. Arch Virol (1980) 1.55
Symptoms, septicemia and death in salmonellosis. Am J Epidemiol (1969) 1.55
Infective endocarditis in narcotic addicts. Ann Intern Med (1968) 1.52
Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones. Diabetologia (2008) 1.50
Coxsackievirus and adenovirus infection. Association with acute febrile and juvenile rheumatoid arthritis. JAMA (1976) 1.45
Comparative in vitro activities of cefmenoxime (SCE-1365) and newer cephalosporin derivatives of clinical utility. Antimicrob Agents Chemother (1982) 1.45
Risk of post-transfusion hepatitis in recepients of blood containing S.H. antigen at Harlem Hospital. Lancet (1971) 1.45
Failure of pneumococcal vaccine in children with sickle-cell disease. N Engl J Med (1979) 1.43
Antibiotic resistance of Salmonella in Europe and the United States. Rev Infect Dis (1982) 1.42
In vitro susceptibility of Campylobacter fetus subsp. jejuni to N-formimidoyl thienamycin, rosaramicin, cefoperazone, and other antimicrobial agents. Antimicrob Agents Chemother (1981) 1.38
Long-term improvement of metabolic control with the insulin pump does not reverse diabetic microangiopathy. Diabetes Care (1984) 1.36
Serum hepatitis specific antigen (SH) in commercial and volunteer sources of blood. Transfusion (1971) 1.29
Hyperglucagonemia in Laennec's cirrhosis. The role of portal-systemic shunting. N Engl J Med (1974) 1.29
Bias and precision of cholesterol analysis by physician's office analyzers. Clin Chem (1987) 1.26
Meningococcal disease in New York City, 1973 to 1978. Recognition of groups y and W-135 as frequent pathogens. JAMA (1980) 1.25
Epidemiology, antimicrobial susceptibility, pathogenicity, and significance of Bacteroides fragilis group organisms isolated at Los Angeles County-University of Southern California Medical Center. Rev Infect Dis (1991) 1.22
Designing appropriate therapy in the treatment of gram-negative bacillary meningitis. JAMA (1982) 1.21
Differences in ability of cell-wall antibiotics to suppress emergence of rifampicin resistance in Staphylococcus aureus. J Antimicrob Chemother (1985) 1.20
In vivo evidence for the contribution of human histocompatibility leukocyte antigen (HLA)-DQ molecules to the development of diabetes. J Exp Med (2000) 1.17
Quinolones for the treatment of infections due to Salmonella. Rev Infect Dis (1991) 1.17
Origins of the "black/white" difference in blood pressure: roles of birth weight, postnatal growth, early blood pressure, and adolescent body size: the Bogalusa heart study. Circulation (2005) 1.17
Conditions affecting the results of susceptibility testing for the quinolone compounds. Chemotherapy (1988) 1.16
Validity of self-reported rheumatoid arthritis in elderly women. J Rheumatol (1996) 1.14
Nitrogen and sodium balance and sympathetic-nervous-system activity in obese subjects treated with a low-calorie protein or mixed diet. N Engl J Med (1980) 1.14
The serum hepatitis related antigen (SH) in illicit drug users. Am J Epidemiol (1970) 1.13
Insulin, glucagon, and somatostatin in normal physiology and diabetes mellitus. Diabetes (1976) 1.13
Treatment of gram-negative bacillary meningitis: role of the new cephalosporin antibiotics. Rev Infect Dis (1983) 1.12
The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model. J Clin Invest (2001) 1.11
Use of cefoxitin, new cephalosporin-like antibiotic, in the treatment of aerobic and anaerobic infections. Antimicrob Agents Chemother (1978) 1.10
Chronic liver disease in asymptomatic narcotic addicts. Ann Intern Med (1972) 1.10
Comparison of the inoculum effects of members of the family Enterobacteriaceae on cefoxitin and other cephalosporins, beta-lactamase inhibitor combinations, and the penicillin-derived components of these combinations. Antimicrob Agents Chemother (1991) 1.10
Reproductive correlates of bone mass in elderly women. Study of Osteoporotic Fractures Research Group. J Bone Miner Res (1993) 1.10
Susceptibility of gram-positive cocci to various antibiotics, including cefotaxime, moxalactam, and N-formimidoyl thienamycin. Antimicrob Agents Chemother (1981) 1.09
Serologic investigations in narcotic addicts. I. Syphilis, lymphogranuloma venereum, herpes simplex, and Q fever. Ann Intern Med (1968) 1.08
Febrile agglutinins in narcotic addicts. Am J Clin Pathol (1970) 1.05
The association of birth weight with developmental trends in blood pressure from childhood through mid-adulthood: the Bogalusa Heart study. Am J Epidemiol (2007) 1.05
Comparison of microtiter broth dilution and agar dilution methods for susceptibility testing of Eikenella corrodens. Antimicrob Agents Chemother (1983) 1.04
Necrolytic migratory erythema without glucagonoma. Arch Dermatol (1979) 1.03
Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole. J Antimicrob Chemother (1993) 1.02
Effect of sequential infusions of glucagon and epinephrine on glucose turnover in the dog. Am J Physiol (1978) 1.02
The impact of legal abortion: redefining the maternal mortality rate. Health Serv Rep (1974) 1.01
Treatment failures of cefotaxime and latamoxef in meningitis caused by Enterobacter and Serratia spp. J Antimicrob Chemother (1987) 1.00
Low birth weight and maternal virus diseases. A prospective study of rubella, measles, mumps, chickenpox, and hepatitis. JAMA (1966) 0.99
Epidemiology as a guide to clinical decisions--II. Diet and coronary heart disease. West J Med (1981) 0.97
Cephalosporin therapy for salmonellosis. Questions of efficacy and cross resistance with ampicillin. Arch Intern Med (1986) 0.97
Experience with the use of cefotaxime in the treatment of bacterial meningitis. Am J Med (1986) 0.97
Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans. J Clin Invest (1979) 0.96
Correlates of bone mineral density in the postmenopausal estrogen/progestin interventions trial. J Bone Miner Res (1994) 0.96
Penetration of cefoxitin into cerebrospinal fluid and treatment of meningitis caused by gram-negative bacteria. Rev Infect Dis (1989) 0.96
Homocyst(e)ine and risk of cerebral infarction in a biracial population : the stroke prevention in young women study. Stroke (1999) 0.95
Amino acid and protein metabolism in diabetes mellitus. Arch Intern Med (1977) 0.95
Controlled trials of the diet-heart hypothesis: some comments on the experimental unit. Am J Epidemiol (1978) 0.94
Putting it all together: summary of the NHLBI Workshop on the Epidemiology of Hypertension in Hispanic American, Native American, and Asian/Pacific Islander American Populations. Public Health Rep (1996) 0.94
Evaluation of two methods for overcoming the antibiotic carry-over effect. Eur J Clin Microbiol Infect Dis (1991) 0.94
Tetanus despite preexisting antitetanus antibody. JAMA (1978) 0.92
Concentrations of cefotaxime and the desacetyl metabolite in serum and CSF of patients with meningitis. J Antimicrob Chemother (1984) 0.92
Serologic investigations in narcotic addicts. 3. Latex fixation, C-reactive protein, "Monotest," serum proteins, and SH antigen. Am J Clin Pathol (1971) 0.91
The Bacon Chow study: maternal nutrition supplementation and birth weight of offspring. Am J Clin Nutr (1981) 0.91
Persistence of transaminase abnormalities in former drug addicts. Ann Intern Med (1972) 0.90
Activity of moxalactam and cefotaxime alone and in combination with ampicillin or penicillin against group B streptococci. Antimicrob Agents Chemother (1981) 0.90
Antibody to hepatitis A and B in children in New York City. Pediatrics (1978) 0.89
Alcohol intake, type of beverage, and the risk of cerebral infarction in young women. Stroke (2001) 0.88
The epidemiology of salmonellosis in New York City. Am J Epidemiol (1969) 0.88
Rubella serology: applications, limitations and interpretations. Am J Public Health (1972) 0.88
Fetal mortality in maternal rubella. Results of a prospective study from 1957 to 1964. Am J Obstet Gynecol (1966) 0.88
Antibiotic resistance of salmonella in northeastern United States 1968-199. N Y State J Med (1971) 0.88
Clindamycin in infective endocarditis. JAMA (1978) 0.87
Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions. Circulation (1998) 0.87